// App-Quantinova.ai

1208 : Levels of Serum Biomarkers from a Two-Year Multicentre Trial Are Associated with Treatment Response on Knee Osteoarthritis Cartilage Loss As Assessed By MRI: An Exploratory Study

Researchers

Presenter

  • Johanne Martel-Pelletier

Principal Investigators

  • Jean-Pierre Raynauld

  • Franois Mineau

  • Franois Abram

  • Patrice Paiement

  • Philippe Delorme

  • Jean-Pierre Pelletier

Medical Centers

  • Osteoarthritis Research Unit, University of Montreal Hospital Research Centre (CRCHUM), Montreal, Quebec, Canada

  • Medical Imaging Research & Development, ArthroLab Inc., Montreal, Canada

  • ArthroLab Inc., Montreal, QC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

Disease

  • N/A

Biomarkers

  • C reactive protein

  • C-Telopeptide of type 1 collagen

  • Matrix metalloproteinase 1

Drug/Treatment

  • Chondroitin sulfate

  • Hyaluronic acid

  • Celecoxib

  • ALT-210

  • Adipsin

Outcome

  • N/A


Study Design

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A